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Flow early in the inspiratory manoeuvre affects the 
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Department of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, 
Western Australia 
Several in vitro and in vivo studies have emphasized the importance of generating a high inspiratory flow 
when using a dry powder inhaler. Little attention has been paid to the influence of the inspiratory flow 
profile on the particle size distribution contained in aerosols generated by these devices. The internal 
volume of a device such as the Turbuhaler is small compared with a vital capacity breath and it is 
possible that all the powder has been drawn from the device before peak inspiratory flow has been 
achieved, particularly if the time to peak inspiratory flow is prolonged. A series of experiments were 
performed to assess the effect of different flow profiles through the Turbuhaler, each with a peak flow of 
60 1 min-‘. 
A 400,ug budesonide Turbuhaler was enclosed in a chamber allowing air to pass unimpeded through 
the dosing channels and entrainment ports. A large three-way tap was used to blow powder from the 
device across a Malvern Mastersizer laser particle sizer which produced a profile of the particle size 
distribution within the aerosol. The rate of increase in flow through the Turbuhaler was determined by 
the rate at which the three-way tap was turned, and recorded by means of a pneumotachograph. 
The rate of increase in flow was found to significantly affect the particle size distribution within the 
aerosol. Failure to attain a flow of 30 1 min - ’ before 150 ml of air had passed through the device resulted 
in the aerosol volume median diameter increasing from less than 6.6 pm to greater than 45.3 pm. 
These results indicate that flow during the initial part of the inspiratory effort may be important in 
determining the characteristics of the aerosol generated by a dry powder inhaler. With more sophisti- 
cated equipment, it might be possible to explore the relationship between flow profile and particle size 
distribution generated by dry powder devices in more detail. 
RESPIR. MED. (1997) 91, 624-628 
Introduction 
Currently available dry powder inhalers (DPIs) 
require energy, imparted by the inspiratory effort of 
the patient, to disaggregate the powder into particles 
small enough to be inhaled. Clinical (l-5) and 
radiolabelled deposition (6) studies have indicated 
that drug delivery to the lungs, from a variety of dry 
powder inhalers, is enhanced as the peak inspiratory 
flow increases. These findings are consistent with the 
results from in vitro studies which have indicated that 
disaggregation of the micronized powder within a dry 
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powder inhaler, such as the Turbuhaler, increases as 
the peak flow through the device increases, resulting 
in a greater proportion of ‘respirable’ particles (7). 
This increase in ‘respirable’ dose results in improved 
delivery of drug to the lungs despite the high in- 
spiratory flows which would normally act to reduce 
delivery of drug to the lower respiratory tract. 
When inhaling through a Turbuhaler, it is likely 
that all the powder is drawn from the device by the 
time the first 100-200 ml have been inhaled (8). 
Hence, the powder may have passed through the 
spiral disaggregation channels and have left the 
device before peak inspiratory flow has been 
achieved. The acceleration applied to particles within 
the device, and the resultant velocity of those particles 
as they pass through the spiral disaggregation chan- 
nels, will vary depending upon the inspiratory flow 
profile of the inspiratory manoeuvre. Therefore, it is 
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FIG. 1. Experimental set up illustrated. A large 
three-way tap permitted air to be directed through 
the Turbuhaler, directing the resultant aerosol 
across the laser of the Malvern particle sizer. The 
rate of increase in flow was determined by the rate 
of opening of the three-way tap. 
entirely possible that the degree of disaggregation will 
depend more on the inhalation flow profile than the 
final flow achieved. 
In order to address this issue, a Malvern Master- 
sizer lazer particle sizer was used to assess the effect of 
altering the rate of increase in flow on the particle size 
distribution generated by a Turbuhaler. 
Methods 
IN VITRO EXPERIMENTS 
These experiments, carried out to assess particle size 
distribution and dose delivered, utilized a ‘spaceship’ 
(Astra Draco, Sweden). This simple device encloses 
the Turbuhaler such that air can flow unimpeded 
through the dosing channels and entrainment ports 
and out through the mouth piece. A large three-way 
tap permitted compressed air to be directed through 
the ‘spaceship’ and hence Turbuhaler as required 
(Fig. 1). A flow of 60 1 min- ‘, calibrated using a 
rotameter (Fischer & Porter Ltd, U.K.), was used 
for all experiments. The flow profile through the 
Turbuhaler could be altered by the rate at which the 
three-way tap was turned from closed to fully open. 
Flow through the ‘spaceship’ was measured using a 
Fleisch no. 2 pneumotachograph (PK Morgan Ltd, 
Chatham, U.K.) Data was collected and analysed 
using Labdat and Anadat programmes (RHT 
infodat, Montreal, Canada). 
Ten healthy adult subjects, four males and six 
females, aged 24-51 years, inhaled through a 
Turbuhaler on two occasions. On one occasion, they 
inhaled with maximum inspiratory effort, and on the 
other they aimed for a peak inspiratory flow of 30 1 
min- ‘. A visual display of their inspiratory flow 
permitted them to aim for this preset value. Flow 
through the ‘spaceship’ was measured using a Fleisch 
no. 2 pneumotachograph, and data were collected 
and analysed using Labdat and Anadat programmes. 
For each run, the inspiratory flow at 150 ml inhaled 
volume was calculated. 
Results 
IN VITRO STUDY 
Flow at 150 ml volume plotted against VMD 
obtained for the individual runs (n= 13) is shown 
in Fig. 2. 
Particle sizing was performed using a Malvern 
Mastersizer X (Malvern Instruments Ltd, U.K.) 
Turbuhalers were placed in a ‘spaceship’ and then 
blown across the path of the laser particle sizer. This 
approach to particle sizing aerosols generated by the 
Turbuhaler has been used in previous studies (9-12). 
The six experiments are shown in Figs 3 and 4. The 
flow profiles are shown in Fig. 3. These are typical of 
those obtained for rapid (l), intermediate (2-5) and 
slow (6) increases in flow. The corresponding particle 
size distribution are shown in Fig. 4. The calculated 
aerosol volume median diameters for the six exper- 
iments were (1) 3.9 pm; (2) 5.0 ,um; (3) 6.6 pm; 
(4) 45.3 pm; (5) 89.3 pm and (6) 100 pm. 
IN VW0 STUDY 
A series of experiments were performed in which When aiming for maximum inspiratory flow, the 
the rate at which the flow increased was varied from inspiratory flow when the inhaled volume reached 
rapid (peak flow achieved within O-35 s) to slow (peak 150 ml ranged from 54 to 73 1 min - ’ (median 58 1 
flow achieved within 3 s). Since it has been suggested 
that it is the first 100-200 ml of volume passing 
through the device that are important (S), the flow 
through the Turbuhaler was quantified after 150 ml 
had passed through it. The flow at 150 ml was then 
plotted against the volume median diameter (VMD) 
for that particular run. 
When using the Malvern particle sizer, data is 
collected as volume data and a VMD can be derived. 
Fifty percent of the total aerosol volume is contained 
in particles greater than this size and 50% of the total 
volume is in particles with a diameter less than this 
value. A mass median aerosol diameter can be calcu- 
lated from this value if all particles have the same 
diameter. Results in this study was presented as VMD 
as the large aggregated particles are likely to have a 
different density to those of the small disaggregated 
particles. 
IN VW0 STUDY 
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FIG. 2. Volume median diameter obtained at 
different flows. Flow was measured after 150 ml of 
air had passed through the Turbuhaler. 
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FIG. 3. Flow profiles from six experiments. Particle 
size distributions measured during each experiment 
are shown in Fig. 4. 
min - ‘). When aiming for 30 1 min - ’ inspiratory 
flows at 150 ml were in the range 21-36 1 mini ’ with 
two subjects obtaining values ~30 1 min - ‘. 
Discussion 
These results suggest that the particle size distribution 
from the Turbuhaler is not entirely dependent on the 
peak inspiratory flow but is influenced to a large 
extent by the flow achieved early in the inspiratory 
effort. Indeed, it appears that the flow achieved within 
the first 150 1 min - ’ inhaled is more important than 
the peak flow, providing this is greater or equal than 
30 1 min-‘. 
Figure 2 suggests that there is a relatively modest 
change in aerosol characteristics as flow at 150 ml 
volume falls towards 30 1 min - ‘, but between 29 and 
25 1 min-1 there is a major change in the character- 
istics of the aerosol generated with a large increase in 
VMD. The small but noticeable trend of a fall in 
VMD as the Aow falls toward 30 1 min- ’ may well be 
reflected in the relative dose reaching the lung. From 
Figs 24, it appears that the characteristics of aero- 
sols generated by the Turbuhaler alter as the rate of 
increase in flow decreases from rapid, as illustrated by 
flow profile in Fig. 3(a), to less rapid as in Fig. 3(b) 
and (c). A much greater change then occurs as the 
rate of increase in flow falls further, as shown in Fig. 
3(d) and (e). 
It is of interest that clinical studies have found 
similar results with relatively little change in perform- 
ance as the flow increases above 30 1 min- ‘, but a 
sudden fall in effectiveness of the device below this 
level. Pedersen et al. found that the bronchodilator 
response in children using a Turbuhaler was unal- 
tered as inspiratory flow fell from 60 to 30 1 min- ’ 
but then dropped significantly as flow fell further to 
221 mini (4). Engel et al. found that reducing 
inspiratory flows from greater than 80 1 min- ’ to 
341min~’ in adults had no obvious effect on the de- 
gree of bronchodilation achieved using a terbutaline 
Turbuhaler and produced only slightly lower plasma 
terbutaline levels (13). 
The magnitude of the change in volume mediated 
diameter observed between profiles ‘3’ and ‘4’ is 
such that it would result in a very large fall in the lung 
dose achieved. As noted earlier, laser particle sizing 
has been used previously for dry powder inhalers 
(9912) and although there may be a small effect on the 
mass median diameter calculated from the volume 
median diameter if there is a change in particle 
density, as is the case for disaggregated and sphe- 
ronized particles, any such differences are mini- 
mal compared with the magnitude of the observed 
changes. The ‘spaceship’ has been specifically 
designed to ensure that airflow through the entrain- 
ment channels and dosing channels is unimpeded and 
hence follows the normal pattern of flow when in 
clinical use. 
This study suggests that flows of 30 1 min - ’ should 
be achieve early during inhalation. The healthy adults 
inhaling to maximal PIF all achieved flows at 150 ml 
well in excess of this figure, but when inhaling to an 
artificially low PIF of 30 1 min- ‘, some individuals 
will fail to achieve this value by 150 ml. One recent 
deposition study in adult subjects using the 
Turbuhaler found a drug delivery to the lungs using a 
PIF of 581 min-’ was approximately double that at 
341 min-l. Subjects were required to achieve PIF 
within 1 s and it is possible that the results obtained 
from subjects when inhaling at the lower PIF were 
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FIG. 4. Particle size distributions from six experiments obtained using Malvern Mastersizer. Experiments l-6 
correspond to flow profiles shown in Fig. 3. 
adversely affected by attempting to achieve this 
artificially low PIF. 
These results imply that when assessing these 
devices, close attention should be paid to both the 
peak inspiratory flow and the inspiratory flow profile 
or ‘rise time’. With more sophisticated equipment 
it might be possible to explore the relationship 
between flow profile and particle size distribution 
generated by dry powder devices in more detail. For 
instance it might be possible to increase flows for 
the first 100 or 200 ml of air passing through the 
device and then reduce the flow in order to define 
the critical volume at which all the powder has left 
the device. 
More importantly, these results emphasize the 
importance of maximal inspiratory effort immediately 
628 M. EVERARD ET AL 
on commencing inspiration when using dry powder 
inhalers. 
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